This report contains market size and forecasts of COVID-19 Medicine in Global, including the following market information:
Global COVID-19 Medicine Market Size 2024-2035, ($ millions)
The global COVID-19 Medicine market is projected to reach US$ million by 2035.
We surveyed the COVID-19 Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Medicine Market, by Type, 2024-2035 ($ millions)
Global COVID-19 Medicine Market Segment Percentages, by Type
Tablet
Injection
Global COVID-19 Medicine Market, by Application, 2024-2035 ($ millions)
Global COVID-19 Medicine Market Segment Percentages, by Application
Patients With Mild Symptoms
Critically Ill
Other
Global COVID-19 Medicine Market, By Region and Country, 2024-2035 ($ Millions)
Global COVID-19 Medicine Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Advanz Pharma
Kyung Poong
Mylan
Novartis
Sanofi
Apotex
Bayer
Guangzhou Baiyunshan Guanghua Pharmaceutical
Ipca Laboratories
Sichuan Sunny Hope
Zydus Cadila
Teva
Sun Pharma
Rising Pharmaceutical
KPC Group
Bristol Laboratories
Shanghai Zhongxisanwei
Shanghai Pharma
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Medicine Overall Market Size
2.1 Global COVID-19 Medicine Market Size: 2023 VS 2035
2.2 Global COVID-19 Medicine Market Size, Prospects & Forecasts: 2023-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Medicine Players in Global Market
3.2 Global Companies COVID-19 Medicine Product & Technology
4 COVID-19 Medicine Companies Profiles
4.1 Advanz Pharma
4.1.1 Advanz Pharma Company Summary
4.1.2 Advanz Pharma Business Overview
4.1.3 Advanz Pharma COVID-19 Medicine Product Offerings & Technology
4.1.4 Advanz Pharma COVID-19 Medicine R&D, and Plans
4.2 Kyung Poong
4.2.1 Kyung Poong Company Summary
4.2.2 Kyung Poong Business Overview
4.2.3 Kyung Poong COVID-19 Medicine Product Offerings & Technology
4.2.4 Kyung Poong COVID-19 Medicine R&D, and Plans
4.3 Mylan
4.3.1 Mylan Company Summary
4.3.2 Mylan Business Overview
4.3.3 Mylan COVID-19 Medicine Product Offerings & Technology
4.3.4 Mylan COVID-19 Medicine R&D, and Plans
4.4 Novartis
4.4.1 Novartis Company Summary
4.4.2 Novartis Business Overview
4.4.3 Novartis COVID-19 Medicine Product Offerings & Technology
4.4.4 Novartis COVID-19 Medicine R&D, and Plans
4.5 Sanofi
4.5.1 Sanofi Company Summary
4.5.2 Sanofi Business Overview
4.5.3 Sanofi COVID-19 Medicine Product Offerings & Technology
4.5.4 Sanofi COVID-19 Medicine R&D, and Plans
4.6 Apotex
4.6.1 Apotex Company Summary
4.6.2 Apotex Business Overview
4.6.3 Apotex COVID-19 Medicine Product Offerings & Technology
4.6.4 Apotex COVID-19 Medicine R&D, and Plans
4.7 Bayer
4.7.1 Bayer Company Summary
4.7.2 Bayer Business Overview
4.7.3 Bayer COVID-19 Medicine Product Offerings & Technology
4.7.4 Bayer COVID-19 Medicine R&D, and Plans
4.8 Guangzhou Baiyunshan Guanghua Pharmaceutical
4.8.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Summary
4.8.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
4.8.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product Offerings & Technology
4.8.4 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine R&D, and Plans
4.9 Ipca Laboratories
4.9.1 Ipca Laboratories Company Summary
4.9.2 Ipca Laboratories Business Overview
4.9.3 Ipca Laboratories COVID-19 Medicine Product Offerings & Technology
4.9.4 Ipca Laboratories COVID-19 Medicine R&D, and Plans
4.10 Sichuan Sunny Hope
4.10.1 Sichuan Sunny Hope Company Summary
4.10.2 Sichuan Sunny Hope Business Overview
4.10.3 Sichuan Sunny Hope COVID-19 Medicine Product Offerings & Technology
4.10.4 Sichuan Sunny Hope COVID-19 Medicine R&D, and Plans
4.11 Zydus Cadila
4.11.1 Zydus Cadila Company Summary
4.11.2 Zydus Cadila Business Overview
4.11.3 Zydus Cadila COVID-19 Medicine Product Offerings & Technology
4.11.4 Zydus Cadila COVID-19 Medicine R&D, and Plans
4.12 Teva
4.12.1 Teva Company Summary
4.12.2 Teva Business Overview
4.12.3 Teva COVID-19 Medicine Product Offerings & Technology
4.12.4 Teva COVID-19 Medicine R&D, and Plans
4.13 Sun Pharma
4.13.1 Sun Pharma Company Summary
4.13.2 Sun Pharma Business Overview
4.13.3 Sun Pharma COVID-19 Medicine Product Offerings & Technology
4.13.4 Sun Pharma COVID-19 Medicine R&D, and Plans
4.14 Rising Pharmaceutical
4.14.1 Rising Pharmaceutical Company Summary
4.14.2 Rising Pharmaceutical Business Overview
4.14.3 Rising Pharmaceutical COVID-19 Medicine Product Offerings & Technology
4.14.4 Rising Pharmaceutical COVID-19 Medicine R&D, and Plans
4.15 KPC Group
4.15.1 KPC Group Company Summary
4.15.2 KPC Group Business Overview
4.15.3 KPC Group COVID-19 Medicine Product Offerings & Technology
4.15.4 KPC Group COVID-19 Medicine R&D, and Plans
4.16 Bristol Laboratories
4.16.1 Bristol Laboratories Company Summary
4.16.2 Bristol Laboratories Business Overview
4.16.3 Bristol Laboratories COVID-19 Medicine Product Offerings & Technology
4.16.4 Bristol Laboratories COVID-19 Medicine R&D, and Plans
4.17 Shanghai Zhongxisanwei
4.17.1 Shanghai Zhongxisanwei Company Summary
4.17.2 Shanghai Zhongxisanwei Business Overview
4.17.3 Shanghai Zhongxisanwei COVID-19 Medicine Product Offerings & Technology
4.17.4 Shanghai Zhongxisanwei COVID-19 Medicine R&D, and Plans
4.18 Shanghai Pharma
4.18.1 Shanghai Pharma Company Summary
4.18.2 Shanghai Pharma Business Overview
4.18.3 Shanghai Pharma COVID-19 Medicine Product Offerings & Technology
4.18.4 Shanghai Pharma COVID-19 Medicine R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Medicine Market Size, 2024 & 2035
5.2 By Region - Global COVID-19 Medicine Revenue, (2024-2035)
5.3 United States
5.3.1 Key Players of COVID-19 Medicine in United States
5.3.2 United States COVID-19 Medicine Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Medicine in Europe
5.4.2 Europe COVID-19 Medicine Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Medicine in China
5.5.2 China COVID-19 Medicine Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 Medicine Market Size Markets, 2024 & 2035
6.2 Tablet
6.3 Injection
7 Sights by Application
7.1 By Application - Global COVID-19 Medicine Market Size, 2024 & 2035
7.2 Patients With Mild Symptoms
7.3 Critically Ill
7.4 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. COVID-19 Medicine Market Opportunities & Trends in Global Market
Table 2. COVID-19 Medicine Market Drivers in Global Market
Table 3. COVID-19 Medicine Market Restraints in Global Market
Table 4. Key Players of COVID-19 Medicine in Global Market
Table 5. Global Companies COVID-19 Medicine Product & Technology
Table 6. Advanz Pharma Company Summary
Table 7. Advanz Pharma COVID-19 Medicine Product Offerings
Table 8. Kyung Poong Company Summary
Table 9. Kyung Poong COVID-19 Medicine Product Offerings
Table 10. Mylan Company Summary
Table 11. Mylan COVID-19 Medicine Product Offerings
Table 12. Novartis Company Summary
Table 13. Novartis COVID-19 Medicine Product Offerings
Table 14. Sanofi Company Summary
Table 15. Sanofi COVID-19 Medicine Product Offerings
Table 16. Apotex Company Summary
Table 17. Apotex COVID-19 Medicine Product Offerings
Table 18. Bayer Company Summary
Table 19. Bayer COVID-19 Medicine Product Offerings
Table 20. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Summary
Table 21. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Medicine Product Offerings
Table 22. Ipca Laboratories Company Summary
Table 23. Ipca Laboratories COVID-19 Medicine Product Offerings
Table 24. Sichuan Sunny Hope Company Summary
Table 25. Sichuan Sunny Hope COVID-19 Medicine Product Offerings
Table 26. Zydus Cadila Company Summary
Table 27. Zydus Cadila COVID-19 Medicine Product Offerings
Table 28. Teva Company Summary
Table 29. Teva COVID-19 Medicine Product Offerings
Table 30. Sun Pharma Company Summary
Table 31. Sun Pharma COVID-19 Medicine Product Offerings
Table 32. Rising Pharmaceutical Company Summary
Table 33. Rising Pharmaceutical COVID-19 Medicine Product Offerings
Table 34. KPC Group Company Summary
Table 35. KPC Group COVID-19 Medicine Product Offerings
Table 36. Bristol Laboratories Company Summary
Table 37. Bristol Laboratories COVID-19 Medicine Product Offerings
Table 38. Shanghai Zhongxisanwei Company Summary
Table 39. Shanghai Zhongxisanwei COVID-19 Medicine Product Offerings
Table 40. Shanghai Pharma Company Summary
Table 41. Shanghai Pharma COVID-19 Medicine Product Offerings
Table 42. By Region? Global COVID-19 Medicine Revenue, (US$, Mn), 2024 & 2035
Table 43. By Region - Global COVID-19 Medicine Revenue, (US$, Mn), 2024-2035
Table 44. By Type ? Global COVID-19 Medicine Market Size, (US$, Mn), 2024 & 2035
Table 45. By Application? Global COVID-19 Medicine Market Size, (US$, Mn), 2024 & 2035
List of Figures
Figure 1. COVID-19 Medicine Segment by Type in 2035
Figure 2. COVID-19 Medicine Segment by Application in 2035
Figure 3. Global COVID-19 Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Medicine Market Size: 2023 VS 2035 (US$, Mn)
Figure 6. Global COVID-19 Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Medicine Revenue Market Share, 2024-2035
Figure 8. By Type - Global COVID-19 Medicine Revenue Market Share, 2024-2035
Figure 9. By Application - Global COVID-19 Medicine Revenue Market Share, 2024-2035
